At the time of writing, Cg Oncology Inc [CGON] stock is trading at $26.56, up 6.84%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The CGON shares have gain 9.84% over the last week, with a monthly amount glided 30.13%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Cg Oncology Inc [NASDAQ: CGON] stock has seen the most recent analyst activity on May 02, 2025, when JP Morgan initiated its Overweight rating and assigned the stock a price target of $41. Previously, Scotiabank started tracking the stock with Sector Perform rating on April 16, 2025, and set its price target to $23. On January 07, 2025, TD Cowen initiated with a Buy rating. UBS started tracking the stock assigning a Buy rating and suggested a price target of $60 on October 24, 2024. RBC Capital Mkts initiated its recommendation with a Outperform and recommended $66 as its price target on September 23, 2024. ROTH MKM started tracking with a Buy rating for this stock on August 28, 2024, and assigned it a price target of $65. In a note dated June 28, 2024, BofA Securities initiated an Buy rating and provided a target price of $65 on this stock.
For the past year, the stock price of Cg Oncology Inc fluctuated between $14.80 and $40.47. Currently, Wall Street analysts expect the stock to reach $55 within the next 12 months. Cg Oncology Inc [NASDAQ: CGON] shares were valued at $26.56 at the most recent close of the market. An investor can expect a potential return of 107.08% based on the average CGON price forecast.
Analyzing the CGON fundamentals
According to Cg Oncology Inc [NASDAQ:CGON], the company’s sales were 0.66M for trailing twelve months, which represents an -90.17% plunge. Gross Profit Margin for this corporation currently stands at 0.99% with Operating Profit Margin at -220.33%, Pretax Profit Margin comes in at -116.57%, and Net Profit Margin reading is -116.57%. To continue investigating profitability, this company’s Return on Assets is posted at -0.1, Equity is -0.11 and Total Capital is -0.19. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It is important to note that Cg Oncology Inc [NASDAQ:CGON] has a current ratio of 30.97. In addition, the Quick Ratio stands at 30.97 and the Cash Ratio stands at 1.83. Considering the valuation of this stock, the price to sales ratio is 3067.49, the price to book ratio is 2.87.
Transactions by insiders
Recent insider trading involved POST LEONARD E, Director, that happened on Apr 28 ’25 when 1000.0 shares were sold. Director, POST LEONARD E completed a deal on Mar 17 ’25 to sell 1000.0 shares. Meanwhile, Director LEONARD E POST bought 4000.0 shares on Mar 17 ’25.
